ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Anticoagulation"

  • 2020 American Transplant Congress

    The Effects of Rivaroxaban and Apixaban on Tacrolimus Pharmacokinetics

    A. C. Scheibner1, C. Franco-Martinez1, E. Kincaide1, R. Hall1, C. Long2

    1Pharmacotherapy Division, College of Pharmacy, The University of Texas at Austin, University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Feik School of Pharmacy, University of the Incarnate Word, University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX

    *Purpose: To clarify the pharmacokinetic impact of rivaroxaban (RIVA) and apixaban (APIX) on tacrolimus (TAC) concentrations.*Methods: Solid organ transplant recipients 18-years or older who were…
  • 2020 American Transplant Congress

    Perioperative Anticoagulation Decreases Graft Thrombosis in Pancreas Transplantation

    N. M. Handy1, L. Skoval1, J. Wingate2, C. Kuhr3, N. Cowan3, J. Brandenberger1

    1Section of General, Thoracic, and Vascular Surgery, Virginia Mason Medical Center, Seattle, WA, 2Department of Urology, Madigan Army Medical Center, Tacoma, WA, 3Section of Urology, Virginia Mason Medical Center, Seattle, WA

    *Purpose: Pancreas transplant thrombosis is the most common cause of graft failure in the early postoperative period, occurring 5-20% of cases. Bleeding (which occurs ~30%…
  • 2020 American Transplant Congress

    Evaluation of Clinical Outcomes in Patients Receiving Antithrombotic Therapy Prior to Kidney Transplantation

    A. Diamond1, C. Antonacci2, K. Lau3, A. Di Carlo3, S. Karhadkar3

    1Pharmacy, Temple University Hospital, Philadelphia, PA, 2Temple University School of Medicine, Philadelphia, PA, 3Surgery, Temple University Hospital, Philadelphia, PA

    *Purpose: Patients with end stage renal disease (ESRD) often have significant cardiovascular comorbidities. Utilization of therapeutic anticoagulation (AC) and/or antiplatelet (AP) therapy poses an increased…
  • 2019 American Transplant Congress

    The Comparative Safety and Efficacy of Direct Acting Oral Anticoagulants Relative to Warfarin Following Liver Transplantation

    A. Santeusanio, A. Weinberg, T. Schiano

    Mount Sinai Hospital, New York, NY

    *Purpose: This study describes the comparative safety and efficacy of direct acting oral anticoagulants (DOACs) relative to warfarin following liver transplantation, at a large academic…
  • 2019 American Transplant Congress

    Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation

    J. Van Keer1, T. Vanassche1, W. Droogne1, S. Rex2, F. Rega3, J. Van Cleemput1, P. Verhamme1, M. Naesens4

    1Cardiology, University Hospitals Leuven, Leuven, Belgium, 2Anesthesiology, University Hospitals Leuven, Leuven, Belgium, 3Cardiovascular Surgery, University Hospitals Leuven, Leuven, Belgium, 4Nephrology, University Hospitals Leuven, Leuven, Belgium

    *Purpose: Atrial fibrillation is common among patients with advanced heart failure who are listed for transplantation. Idarucizumab is a monoclonal antibody fragment that was developed…
  • 2019 American Transplant Congress

    Variables Associated with Intracardiac Thrombus during Orthotopic Liver Transplant: A Retrospective Single-Center Study

    M. Groose1, J. Mezrich2, L. Hammel1

    1Department of Anesthesiology, University of Wisconsin, Madison, WI, 2Department of Surgery, University of Wisconsin, Madison, WI

    *Purpose: Intracardiac thrombus (ICT) is an intraoperative complication during orthotopic liver transplantation (OLT) with high mortality. Patients with end stage liver disease have compromised coagulation…
  • 2019 American Transplant Congress

    Anticoagulation in Post-Liver Transplant Recipients with Portal Vein Thrombosis

    L. Schumacher1, L. Lindberg1, D. Alonso2, R. Gilroy3, J. Krong4, L. Dong4, S. LeCorchick1

    1Department of Pharmacy, Intermountain Medical Center, Murray, UT, 2Transplant Surgery, Intermountain Medical Center, Murray, UT, 3Transplant Hepatology, Intermountain Medical Center, Murray, UT, 4Department of Transplant, Intermountain Medical Center, Murray, UT

    *Purpose: The purpose of this study is to compare safety and efficacy outcomes in liver transplant recipients with portal vein thrombosis (PVT) at the time…
  • 2019 American Transplant Congress

    Impact of Prolonged Venous Thromboembolism Prophylaxis on 30-Day Hemostatic Outcomes Following Kidney Transplantation in Patients with Hypercoagulable Risk Factors

    V. Behbahani, A. Santeusanio, S. Ames, R. Shapiro

    Mount Sinai Hospital, New York, NY

    *Purpose: A number of hypercoagulable states have been identified through laboratory testing that place patients at greater risk for thrombosis; however, the appropriate management of…
  • 2019 American Transplant Congress

    A Comparison of the Safety and Efficacy of Apixaban Use in Renal Transplant vs. Non-Renal Transplant Recipients

    T. Loosier, K. Gutierrez, A. James, A. Dodson

    University of Alabama at Birmingham Hospital, Birmingham, AL

    *Purpose: Background: Utilization of direct-acting oral anticoagulants has become a preferred method for chronic anticoagulation in patients with atrial fibrillation (AF) or venous thromboembolism (VTE).…
  • 2019 American Transplant Congress

    Novel Oral Anticoagulants in Kidney Transplantation: Results from a Pilote Study

    J. Leon, J. Zuber, L. Amrouche, D. Anglicheau, G. Divard, C. Legendre, R. Sberro-Soussan

    Adult Transplantation, Necker Hospital, Paris, France

    *Purpose: Oral anticoagulation therapy is frequently prescribed to kidney transplant recipients, for prevention and treatment of thrombotic events. Over the past ten years, novel oral…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences